Super League Enterprise, Inc. current report, Q2 FY2025

Business Context and Reporting Period

This Form 8-K Current Report is filed by Super League Enterprise, Inc. (SLE) for the period ending May 12, 2025. The filing primarily addresses the completion of a public offering of common stock, the termination of a prior equity purchase agreement, and the scheduling of the 2024 Annual Meeting of Stockholders.

Key Financial Metrics and Capital Events

  • Public Offering: The Company closed a public offering of 5,117,647 shares of Common Stock at a public price of $0.17 per share.
  • Net Proceeds: The Company received approximately $700,400 in net proceeds after deducting underwriting discounts, commissions, and estimated offering expenses.
  • Over-Allotment Option: The underwriter, Aegis Capital Corp., was granted a 45-day option to purchase an additional 767,647 shares.
  • Use of Proceeds: Funds are designated for working capital, general corporate purposes, and repayment of a portion of the Company's indebtedness.
  • Financial Statements: This filing does not contain revenue, profit, cash flow, or margin data. The filing text does not provide a clear value for current debt levels or liquidity ratios beyond the intent to repay indebtedness.

Material Changes and Agreements

  • Termination of Purchase Agreement: On May 8, 2025, the Company mutually terminated an equity purchase agreement entered into on February 14, 2025, which allowed for the sale of up to $2.9 million of common stock. No early termination penalties were incurred.
  • Underwriting Agreement: A new underwriting agreement was executed with Aegis Capital Corp. on May 9, 2025, facilitating the offering described above.

Outlook, Governance, and Risks

  • Annual Meeting: The 2024 Annual Meeting of Stockholders is scheduled for June 9, 2025. The record date is April 16, 2025.
  • Shareholder Proposals: Due to the advancement of the meeting date, the deadline for stockholder proposals and director nominations is May 15, 2025.
  • Risk Factors: The filing includes standard forward-looking statement disclaimers. Actual results may differ due to market conditions and risks detailed in the Prospectus Supplement and the Company's 2024 Form 10-K.

Investor Verification Checklist

  • Verify the final net proceeds of $700,400 against the total shares issued and underwriting fees in the Prospectus Supplement.
  • Confirm the specific amount of indebtedness intended to be repaid with the offering proceeds.
  • Review the terminated February 2025 equity purchase agreement to understand the capital raising strategy shift.
  • Check the upcoming 2024 Annual Meeting proxy statement for any changes in director nominations or shareholder proposals submitted by the May 15, 2025 deadline.
  • Monitor the status of the 45-day over-allotment option for the additional 767,647 shares.